NYSE Content Update: Expedition Therapeutics Secures $115 Million Series B
NYSE Content Update: Expedition Therapeutics Secures $115 Million Series B

Wed, August 5, 2026 at 12:56 PM UTC
0

NYSE issues a pre-market daily advisory direct from the trading floor.
NEW YORK, Aug. 5, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.
Ashley Mastronardi delivers the pre-market update on August 5th
The Dow Jones Industrial Average and S&P 500 will look to build off fresh records on hopes of a deal in the Middle East.The Dow surpassed 54,000 for the first time ever.The S&P 500 clinched its first-ever close above 7,700.
Expedition Therapeutics Founder & CEO Yi Larson will join NYSE Live following her firm's latest funding round.The company says the first patients have been dosed in its Phase 2 clinical trial for EXPD-101, a next-gen treatment for COPD.
Zeta Global (NYSE: ZETA) CEO David Steinberg will join NYSE Live to deliver the biggest takeaways from the company's Q2 earnings report.The firm says it posted its 20th straight 'beat-and-raise' quarter and achieved the 'Rule of 64.'
Opening Bell AB InBev (NYSE: BUD) rings the NYSE Opening Bell
Advertisement
Closing Bell Blend (NYSE: BLND) celebrates its 5th anniversary of listing
For market insights, IPO activity, and today's opening bell, download the NYSE TV App: TV.NYSE.com
View original content to download multimedia: https://www.prnewswire.com/news-releases/nyse-content-update-expedition-therapeutics-secures-115-million-series-b-302843756.html
SOURCE New York Stock Exchange
Source: “AOL Money”